Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlateswith reoxygenation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlateswith reoxygenation

Published:2001-10 Issue:2 Volume:51 Page:483-493
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Petersen Cordula,Zips Daniel,Krause Mechthild,Schöne Kerstin,Eicheler Wolfgang,Hoinkis Cordelia,Thames Howard D,Baumann Michael

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference33 articles.

1. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer;Dische;Radiother Oncol,1997

2. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation, and two variants of accelerated fractionation to standard fractionation radiotherapy for head, and neck squamous cell carcinomas;Fu;Int J Radiat Oncol Biol Phys,2000

3. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head, and neck cancers;Horiot;Radiother Oncol,1997

4. Conventional radiotherapy as the primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week—preliminary report from DAHANCA 6 and 7 trial;Overgaard;Radiother Oncol,1996

5. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer;Saunders;Lancet,1997

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor hypoxia and radiotherapy: A major driver of resistance even for novel radiotherapy modalities;Seminars in Cancer Biology;2024-01

2. Cytotoxic activity of isoquinoline alkaloids and herbal extracts from selected plants against human cancer cell lines: harnessing the research potential in cancer drug discovery with modern scientific trends and technology;Toxicology Research;2023-11-23

3. Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors;Acta Oncologica;2023-09-08

4. Optimizing Lung Cancer Radiotherapy Treatments Using Personalized Dose-Response Curves;Medical Radiology;2022

5. Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC);Cancers;2021-11-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3